CDC: January to July 2018 Saw Decrease in Opioid Deaths
Opioid deaths decreased during January to July 2018, while deaths from illicitly manufactured fentanyl (IMF) increased during the same period.
Opioid-Use Disorder
Nonmedical Prescription Opioid Use by Young Adults Linked to Depression
More than 60% of young adults who reported nonmedical prescription opioid use in the previous 30 days screened positive for depressive symptomology using the Center for Epidemiologic Studies Short Depression Scale.
Purdue Pharma Tentatively Reaches Settlement in Opioid Lawsuits
OxyContin maker Purdue Pharma has reached a tentative settlement with a coalition of states and local governments that sued the company over its role in America’s ongoing opioid crisis.
Opioid Maker Purdue Pharma Expected to File for Bankruptcy
Settlement talks with OxyContin maker Purdue Pharma over its role in the U.S. opioid crisis have reached a stalemate and the company is expected to file for bankruptcy.
Readdressing Opioid Dose Tapering and Buprenorphine Indications
Recognizing prescription opioid dependence and expanding the use of buprenorphine could improve the quality of life for patients with chronic pain.
White House Announces Nearly $2 Billion in Grants to Fight Opioid Epidemic
Nearly $2 billion in grants to help fight the US opioid epidemic will be handed out to states and local governments.
Johnson & Johnson Fined $572 Million Over Opioid Drug Crisis
The verdict could have huge implications as other states and communities target pharmaceutical companies.
Training in Ethics and Prescribing May Curb Opioid Overprescribing
As opioid overprescribing is a key contributor to the current opioid crisis, implementing appropriate prescribing strategies in medical education may prepare future physicians to appropriately and ethically prescribe opioids.
Extended-Release Naltrexone, Opioid Use, and Treatment Adherence
Individuals taking extended-release injection naltrexone for opioid use disorder may be less likely to drop out of treatment after a single use of opioids compared with patients receiving placebo.
The Link Between Misconceptions About Opioid Use Disorders and Current Policies
An estimated 20 million people in the United States meet the criteria for substance use disorder.
Next post in Addiction
